The effects of low-molecular-weight heparin on trophoblasts

被引：0
|
作者：
Rimon, E. [1 ]
Kupferminc, M. [1 ]
机构：
[1] Lis Maternal Hosp, Tel Aviv Med Ctr, Dept Maternal Fetal Med, Tel Aviv, Israel
来源：
THROMBOSIS RESEARCH | 2013年 / 131卷
关键词：
D O I：
10.1016/S0049-3848(13)70145-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S102 / S102
页数：1
相关论文
共 50 条
  • [21] HEPARIN AND LOW-MOLECULAR-WEIGHT HEPARINS
    HIRSH, J
    CORONARY ARTERY DISEASE, 1992, 3 (11) : 990 - 1002
  • [22] LOW-MOLECULAR-WEIGHT HEPARIN TO BE MARKETED
    不详
    CLINICAL PHARMACY, 1993, 12 (07): : 471 - &
  • [23] Low-molecular-weight heparin and cancer
    Zacharski, LR
    Ornstein, DL
    Mamourian, AC
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2000, 26 : 69 - 77
  • [24] Low-molecular-weight heparin for thromboprophylaxis
    Camporese, Giuseppe
    Bernardi, Enrico
    CURRENT OPINION IN PULMONARY MEDICINE, 2009, 15 (05) : 443 - 454
  • [25] ANGIOGENESIS AND LOW-MOLECULAR-WEIGHT HEPARIN
    ROBINSON, LA
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1994, 24 (01) : 272 - 273
  • [26] Low-molecular-weight heparin for PE
    Grimm, KJ
    French, L
    JOURNAL OF FAMILY PRACTICE, 1997, 45 (06): : 467 - 468
  • [27] Low-molecular-weight heparin in oncology
    Zacharski, LR
    Loynes, JT
    ANTICANCER RESEARCH, 2003, 23 (3C) : 2789 - 2793
  • [28] Dalteparin: A low-molecular-weight heparin
    Howard, PA
    ANNALS OF PHARMACOTHERAPY, 1997, 31 (02) : 192 - 203
  • [29] DANAPAROID IS NOT A LOW-MOLECULAR-WEIGHT HEPARIN
    SPINLER, SA
    CZIRAKY, MJ
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1994, 51 (16): : 2050 - 2050
  • [30] EFFECTS OF LOW-MOLECULAR-WEIGHT HEPARIN IN EXPERIMENTAL DIABETIC NEPHROPATHY
    OTURAI, PS
    KOFOEDENEVOLDSEN, A
    DECKERT, T
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 1045 - 1045
12345